• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Detection of pathogenic genetic variants in early-onset atrial fibrillation

byYuchen DaiandMichael Pratte
September 16, 2021
in Cardiology, Chronic Disease, Emergency, Genetics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Genetic testing in patients with early-onset atrial fibrillation, via major commercial arrhythmia and cardiomyopathy gene panels, were able to detect a disease-associated variant in approximately 10% of patients, with a higher rate in those diagnosed before the age of 30 years.

2. Disease-associated variants in atrial fibrillation were more common in genes associated with inherited cardiomyopathies than inherited channelopathies.

Evidence Rating Level: 2 (Good)

Study Rundown: Atrial fibrillation (AF) is the most common type of supraventricular tachyarrhythmia where the mainstay of diagnosis and monitoring focuses on the assessment of cardiac rhythm, structure, and function. Currently, genetic testing is not recommended in patients with AF. However, recent data has suggested that early-onset AF may be suggestive of a more serious underlying inherited cardiomyopathy or arrhythmia syndrome. This cohort study analyzed genes currently included on major commercial arrhythmia and cardiomyopathy gene panels to evaluate the frequency of disease-associated variants according to age, specific inherited syndromes, and individual genes. The main endpoint of the analysis was classification of rare variants using American College of Medical Genetics and Genomics (ACMG) criteria: benign, likely benign, variant of undetermined significance, likely pathogenic, or pathogenic. Among 1,293 patients with early-onset AF who underwent whole genome sequencing, disease-associated variants in cardiomyopathy and arrhythmia genes were identified in 10.1% of patients younger than 66 years and 16.8% of individuals younger than 30 years. Furthermore, disease-associated variants were more prevalent in genes associated with inherited cardiomyopathy syndromes than inherited arrhythmia syndromes. These findings suggested that genetic testing in patients with early-onset AF via major commercial arrhythmia and cardiomyopathy gene panels were able to detect a disease-associated variant in approximately 10% of patients, with a higher rate in those diagnosed before the age of 30 years. These results are encouraging in supporting the use of genetic testing in patients presenting with early-onset AF. A limitation of this study was that the patient cohort was consisted predominately of people of European descent where the prevalence of rare variants associated with AF in individuals of underrepresented ethnicities is unclear. Further study is needed on these other ethnic groups to help stratify risk associated with ethnicity and increase generalizability of the study’s findings.

Click to read the study in JAMA Cardiology

Click to read an accompanying editorial in JAMA Cardiology

Relevant Reading: Broad genetic testing in a clinical setting uncovers a high prevalence of titin loss-of-function variants in very early onset atrial fibrillation

RELATED REPORTS

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

Rivaroxaban associated with significantly increased risk of major ischemic or hemorrhagic events versus apixaban in patients with atrial fibrillation

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

In-Depth [prospective cohort]: This prospective, single-center, observational cohort study included 1,293 patients with AF (934 [72.2%] male; median [IQR] age at enrollment, 56 [48-61] years; median [IQR] age at AF diagnosis, 50 [41-56] years) diagnosed before 66 years of age from November 1999 to June 2015 and underwent whole genome sequencing through the National Heart, Lung, and Blood Institute’s Trans-Omics for Precision Medicine program. Data analysis was performed between October 2020 and March 2021 where sequencing data from commercial cardiomyopathy and arrhythmia panels (145-gene panel) were analyzed using an automated process followed by manual review by a panel of independent, blinded reviewers. In total, genetic testing identified 131 patients (10.1%) with a disease-associated variant, 812 (62.8%) with a variant of undetermined significance, 92 (7.1%) as heterozygous carriers for an autosomal recessive disorder, and 258 (20.0%) with no suspicious variant. Disease-associated variants were most prevalent in patients diagnosed before the age of 30 years (20 of 119 [16.8%; 95%CI, 10.0%-23.6%]) and lowest after the age of 60 years (8 of 112 [7.1%; 95%CI, 2.4%-11.9%]). Lastly, disease-associated variants were most common in genes associated with inherited cardiomyopathy syndromes than inherited arrhythmia syndromes, where the most affected genes were TTN (n = 38), MYH7 (n = 18), MYH6 (n = 10), LMNA (n = 9), and KCNQ1 (n = 8).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atrial fibrillationgenetic mutationgenetic variantrisk stratification
Previous Post

#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas

Next Post

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

RelatedReports

Stroke expansion following intra-arterial therapy may explain worse outcomes
Cardiology

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

April 19, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Cardiology

Rivaroxaban associated with significantly increased risk of major ischemic or hemorrhagic events versus apixaban in patients with atrial fibrillation

December 22, 2021
#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation
StudyGraphics

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

December 22, 2021
Resident involvement may not increase postoperative complications in neurosurgery
Cardiology

Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

December 14, 2021
Next Post
#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Mental health in young adults may be linked to sleep chronotype

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.